Detalles de la búsqueda
1.
Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia.
BMC Psychiatry
; 22(1): 250, 2022 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35395757
2.
Real-world assessment of treatment inertia in the management of patients treated for major depressive disorder in the USA.
J Comp Eff Res
; 13(1): e230091, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37987716
3.
Health care resource utilization and costs of California Medicaid patients with schizophrenia treated with paliperidone palmitate once monthly or atypical oral antipsychotic treatment.
Curr Med Res Opin
; 33(4): 723-731, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28044455
4.
Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics.
Drugs Real World Outcomes
; 2(4): 377-385, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26689953
5.
Follow-up Care among Medicaid Patients with Schizophrenia treated with Antipsychotics in the Inpatient Setting.
J Health Econ Outcomes Res
; 2(1): 29-40, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-37664086
6.
An evaluation of the impact of patient cost sharing for antihypertensive medications on adherence, medication and health care utilization, and expenditures.
Patient Prefer Adherence
; 6: 63-72, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22298945
Resultados
1 -
6
de 6
1
Próxima >
>>